Abstract

BackgroundIn contrast to PD-1+CD8+ T cells, PD-1+CD4+ T cells and their impact in tumor progression and immunotherapy response remain relatively unexplored. We previously reported that PD-1hiFoxp3-CD4+ T cells (4PD1hi) from...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call